During the XII Congress of the Iberoamerican Society of Neurourology and Urogynecology, held in Chiclana de la Frontera (Cádiz), Lluis Peri, Urology Medical Clinical Hospital of Barcelona, presented the drug ‘Ialuril’, the new option treatment of bladder pain syndrome, which aims to repair the damaged layer of the bladder urothelium in different clinical situations.
“Ialuril” is a medical device that combines Pharma Laboratories Gebro high concentrations of chondroitin sulfate, hyaluronic acid, essential components of the bladder wall, in addition to the presence of calcium, which facilitates binding of these compounds to the wall bladder. It is administered intravesical.
A disease that affects more women
Painful bladder syndrome groups many situations. The common denominator is the presence of pelvic pain persisted for at least six months and others are characteristic symptoms of frequency and urgency. This is a disease that usually affects more women, with a ratio of 9 women for every man affected. However, the reasons are unknown.
According Lluis Peri, “what is clear is that there must be some hormonal factor, anatomical or any other female that predisposes to this disease.” The specialist I remember the seriousness of the consequences that occur in the quality of life of people suffering from this disease.
Meanwhile, Pilar Cabezon, doctor and patient suffering from this disease, said: “The pain was continuous. Urgency and frequency of urination prevented me distance myself from home. Symptomatology remains This overnight sleep preventing continuous” . However, he admitted that since being treated with ‘Ialuril’, noted a gradual improvement in their status. In this regard, Lluis Peri said that “in the prevention of recurrent urinary tract infections, this drug has proved more effective than placebo and some treatments currently used as oral antibiotics administered prophylactically.”